Designing Effective Media-Fill Tests for Sterile Compounders

Understanding the Purpose of Media-Fill Testing

A media-fill test simulates the aseptic compounding process using microbiological growth media instead of actual medications. The goal is to identify breaches in aseptic technique or environmental control that could result in contamination. Successful completion demonstrates a compounder’s ability to prevent microbial contamination under realistic working conditions.

Key Elements in Media-Fill Test Design

• Simulation of Actual Workflows: The MFT should closely replicate the most challenging and representative compounding procedures performed in your pharmacy. This includes the use of all relevant equipment, garbing procedures, and manipulations, whether compounding non-HD or HD products.
• Appropriate Media Selection: Use a growth medium such as tryptic soy broth (TSB) that supports the proliferation of a wide range of microorganisms. Ensure that the media is compatible with the compounding devices and processes in use.
• Environmental Controls: Perform testing under the same conditions as routine compounding, including within primary engineering controls (PECs) like laminar airflow workbenches (LAFWs) or biological safety cabinets (BSCs). Additionally, the MFT must capture elements that could potentially affect the sterility of the CSP, such as number of personnel in the buffer room or segregated compounding area (SCA).
• Documentation and Evaluation: Maintain thorough records of each media-fill, including procedures followed, personnel tested, and results. Any growth detected indicates failure and necessitates an investigation, remediation, and retesting.

Testing Considerations for Non-HD and HD Compounding

Sterile compounders often perform both non-hazardous and hazardous drug compounding, each with unique risk profiles. When designing media-fill tests, it’s important to evaluate competency in both environments:

• Non-HD Media-Fill Tests: Simulate standard sterile compounding techniques in designated non-hazardous areas. Focus on aseptic technique and minimizing touch contamination.
• HD Media-Fill Tests: Conduct in line with USP requirements, including closed-system drug transfer devices (CSTDs) where applicable.

Initial and Ongoing Media-Fill Testing Schedules

If a staff member compounds non-HD and HD CSPs, both non-HD and HD media-fill tests should be performed initially upon hire and before any independent compounding activity. This ensures that personnel are proficient in the specific aseptic techniques required for each environment.

For ongoing competency assessments, best practice is to alternate testing every six months: conduct a non-HD media-fill test at one six-month interval, followed by an HD media-fill test at the next, and so on. This approach ensures yearly assessment in each environment while reducing testing fatigue and maintaining compliance with USP standards. If a compounder fails either test, retraining and successful retesting in the failed modality must occur.

Conclusion

A well-designed media-fill testing program is vital for sterile compounders, safeguarding patient safety and regulatory compliance. By carefully simulating non-HD and HD workflows, rigorously documenting outcomes, and adhering to an initial and ongoing testing schedule, pharmacies can ensure their teams are prepared to deliver the highest quality compounded sterile preparations.